Web11 apr. 2024 · La ricerca di Morgan Stanley conferma la raccomandazione e mantiene il giudizio Neutral. Il prezzo obiettivo è stato alzato ed è ora fissato a 42 USD rispetto ai precedenti 40 USD . 12 aprile 2024 WebAll news about IONIS PHARMACEUTICALS, INC. 04/11: Morgan Stanley Adjusts Price Target on Ionis Pharmaceuticals to $42 From $40, Maintains.. MT. 04/04: Transcript : Ionis Pharmaceuticals, Inc. Presents at Guggenheim Healthcare Ta.. CI. 03/30: Ionis - New data presented at AD/PD2024 show IONIS-MAPT Rx substantially reduced tau pr.. …
ISIS Stock Price Today NASDAQ IONS Live Ticker - Investing.com
Web9 apr. 2024 · Xponance Inc. increased its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 14.0% during the 4th quarter, ... Daily Ratings & News … Web30 mrt. 2024 · IONIS PHARMACEUTICALS, INC. : Stock Market News and Information IONS US4622221004 MarketScreener Homepage Equities United States Nasdaq … tthe top rated firm mattress
Ionis Pharmaceuticals, Inc. gibt neue, auf der Ad/Pd(Tm)2024 ...
Web12 apr. 2024 · Posted by MarketBeat News on Apr 12th, 2024. Ionis Pharmaceuticals ( NASDAQ:IONS – Get Rating) had its price target boosted by Morgan Stanley from … Web11 apr. 2024 · Morgan Stanley bestätigt seine Meinung zu den Aktien und bleibt neutral. Zuvor auf 40 USD festgelegt, wurde der Zielpreis auf 42 USD angehoben. 11 April 2024 Web11 apr. 2024 · Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC), Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC – Research Report), Ionis … tipranks.com - Brian Anderson• 40m Read more on … phoenix coaching staff